Marked improvement of neuropsychiatric symptoms following control of allergy symptoms with the use of humanized murine anti-IgE antibody (omalizumab) in 2 patients with severely limited expressive language
Crossref DOI link: https://doi.org/10.1186/S13223-015-0105-X
Published: 2015-12
Update policy: https://doi.org/10.1007/SPRINGER_CROSSMARK_POLICY
Jyonouchi, Harumi
Funding for this research was provided by:
Autism Research Institute
Jonty Foundation
